arrow
M

Mohd Zulfakar Mazlan

Department of Anesthesiology and Intensive Care
H指数:13
被引数:1,354

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons

铜绿假单胞菌血流感染中cefiderocol与标准疗法的随机对照试验:基于DOOR和广义成对比较的获益与风险评估

2026-09-070
PRE
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment

美罗培南在第一天给药剂量优化及在无显著肾功能损害的重症患者的稳态给药

2025-10-290
OA
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial

西他赛尔 versus 标准疗法用于医院获得性和 healthcare-associated 革兰氏阴性细菌血流感染(GAME CHANGER 试验):一项开放标签、平行组、随机试验

2025-10-060
PRE
Epidemiology and long-term outcomes of critically ill patients with severe AKI in India and Southeast Asia

印度和东南亚危重患者中严重AKI的流行病学和长期预后

2025-07-140
PRE
Evidence based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU): protocol for type III hybrid implementation-effectiveness study (vol 20, 12, 2025)

基于证据的处方管理质量改进在ICU中的应用(EQUIPS-ICU):类型III混合实施-效果研究方案(卷20,12,2025)

2025-03-310
OA